Literature DB >> 3655045

Tumor invasion of the anterior skull base: a comparison of MR and CT studies.

M R Paling1, W C Black, P A Levine, R W Cantrell.   

Abstract

Seven patients who had tumors arising in the anterior face or paranasal sinuses and invasion of the anterior skull base were evaluated with magnetic resonance (MR) and high resolution CT. Magnetic resonance was superior in evaluating tumor encasement of the carotid artery and invasion of the cavernous sinus; for assessing the relationship of the tumor to the anterior brain, optic nerves, and optic chiasm; in providing coronal images free from dental artifact; and in determining tumor extent within the infratemporal fossa. Bone destruction was more easily observed on CT than MR.

Entities:  

Mesh:

Year:  1987        PMID: 3655045     DOI: 10.1097/00004728-198709000-00016

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  [Skull base tumors].

Authors:  F Ahlhelm; A Nabhan; N Naumann; I Grunwald; K Shariat; W Reith
Journal:  Radiologe       Date:  2005-09       Impact factor: 0.635

2.  Squamous cell carcinoma involving the calvaria and base of the skull.

Authors:  R Sigal; G Mamelle; J Bosq; D Vanel
Journal:  Skeletal Radiol       Date:  1995-04       Impact factor: 2.199

3.  Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.

Authors:  Fonyuy Nyuyki; Michail Plotkin; Reinhold Graf; Roger Michel; Ingo Steffen; Timm Denecke; Lilli Geworski; Daniel Fahdt; Winfried Brenner; Reinhard Wurm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-18       Impact factor: 9.236

4.  Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.

Authors:  Reinhold Graf; Michail Plotkin; Ingo G Steffen; Reinhard Wurm; Peter Wust; Winfried Brenner; Volker Budach; Harun Badakhshi
Journal:  Head Face Med       Date:  2012-01-04       Impact factor: 2.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.